• Published on: Aug 03, 2021
  • 2 minute read
  • By: Second Medic Pulmonologist

What Is Mucormycosis & COVID-19 Associated With Mucormycosis ?

  • WhatsApp share link icon
  • copy & share link icon
  • twitter share link icon
  • facebook share link icon

Mucormycosis is a rare but serious infectious disease that can be caused by inhaling spores from the ubiquitous fungi. These organisms, commonly found in soil and composts are also present on fallen leaves or animal dung. Less contagious than other types of infections, mucormycosis mainly affects people who have weakened immune systems because it cannot spread like others that do not need an outside source to enter one's body via open wounds or cuts. Mucoromyces mean "fuzz," which describes their appearance when seen under a microscope with long branching filaments called pseudohistiocysts arising off these branched threads (hyphae).

Mucormycosis is a rare but serious angio-invasive infection caused by ubiquitous fungi. The spores of these fungi can be inhaled and then infect the lungs, sinuses, or extend into brain tissue to cause mucormycosis in people who are immunocompromised. Mucoromyces has been found all over Earth with it mainly affecting those living on farms due to contact from animal dung containing high quantities of this fungus type as well as compost piles where fresh manure falls leaves cover vegetable gardening beds that may have fallen nearby leading most cases occurring near woodland areas such before dorms at college campuses were previously thought responsible for respiratory infections since they might contain bacteria like tuberculosis which also needs oxygenated.

Fungal infections, including mucormycosis, aspergillosis and invasive candidiasis, have been reported in patients with severe COVID-19 or those recovering from the disease and are associated with a high risk of serious illness. India has recently seen an increase in cases that present this way when compared to other countries where these types of fungus thrive. Prevention needs to focus on making sure people who suffer from Covid-19 maintain better glycemic control so they do not develop any fungal infection like Mucoromyces Cerealis (a subtype found more often outside India) which can cause pneumonia if untreated or brain damage if left too long without treatment because it is resistant both systemic corticosteroids/other.

Mucormycosis, an invasive fungal infection that can lead to death, has been reported in patients with severe COVID-19. The Indian government recently noted a surge of cases and the spread of this dangerous condition is attributed largely to poor glycemic control among those living with the disease or recovering from it.

Fungal infections, including mucormycosis and invasive candidiasis, have been reported in patients with severe COVID-19 or those recovering from the disease. India has seen an uptick of cases due to fungal infection caused by COVID-19 along with a surge in people who are severely affected because they were not diagnosed early on while fighting off the virus. Prevention for this type of fungus is increased monitoring when trying to apply systemic corticosteroids/other immunomodulating drugs on these patients just as much as it would be if there was no sign that someone had ARDS (acute respiratory distress syndrome).

Mucormycosis is not contagious and does not spread by contact from person to person. This fungus has been found in the environment, but transmission occurs through inhalation or ingestion of spores from the environment. Although most cases are sporadic, healthcare-associated outbreaks have occurred after the use of adhesive bandages made out wood tongue depressors as well as linens with lackadaisical hygiene standards at hospitals that result in fungal exposure on surfaces like walls and floors which can lead to airborne infection if those areas aren't properly cleaned up soon enough. Mucormicosis primarily affects sinuses or lungs after inhaling spores from air when it's breathed directly into them.

Read Blog
Chronic Disease Management in Digital India: How SecondMedic Is Transforming Long-Term Care

Chronic Disease Management in Digital India: How SecondMedic Is Transforming Long-Term Care

In India, chronic diseases are the silent epidemic. From diabetes and hypertension to COPD and heart disorders, these conditions affect millions - and demand long-term, consistent care.

Traditionally, managing these illnesses meant frequent hospital visits and reactive treatment. But in Digital India, technology has changed the game. Platforms like SecondMedic are making chronic care predictive, preventive, and personalized.

 

The Chronic Disease Burden in India

According to the World Health Organization (WHO), chronic diseases account for over 60% of deaths in India.
The Indian Council of Medical Research (ICMR) reports that:

  • 1 in 4 Indians suffer from a chronic condition.

  • 77 million people are diabetic.

  • 220 million live with hypertension or cardiovascular risk.
     

The challenge? Managing these conditions continuously - not just during hospital visits.

 

How Digital Transformation Is Changing the Game

The rise of digital healthcare - teleconsultations, remote monitoring, and AI analytics - has turned chronic care into an ongoing, data-driven process.

Predictive analytics, powered by AI, identifies early warning signs and suggests interventions before crises occur.
Wearable devices track vital parameters like heart rate, oxygen, glucose, and BP 24×7.
Cloud-based health records allow doctors to review trends remotely and adjust treatment instantly.

A NASSCOM Digital Health Report (2024) notes that remote monitoring adoption has increased by 68% since 2020, saving up to 25% in hospitalization costs.

 

How SecondMedic Makes Chronic Care Smarter

SecondMedic combines medical expertise with cutting-edge technology to empower patients:

  • Remote Doctor Consultations - Regular virtual follow-ups for chronic patients.

  • AI-Powered Health Dashboard - Smart algorithms detect risk trends and trigger alerts.

  • Lab & Diagnostic Integration - Automatic syncing of test results for doctor review.

  • Personalized Health Plans - Tailored diet, exercise, and medication guidance.

  • Continuous Monitoring - Devices and data integration for real-time oversight.
     

This holistic approach ensures proactive management - keeping patients healthier and reducing the chance of emergencies.

“Digital tools have allowed us to shift from managing illness to maintaining wellness.”
- Dr. Meenakshi Sharma, Medical Director, SecondMedic

 

Real-World Impact & Market Insights

  • Market Growth: India’s chronic care management market is projected to reach USD 11.2 billion by 2030, growing at CAGR 12.5% (IMARC Group 2025).

  • Digital Adoption: 74% of doctors use digital tools to monitor chronic patients remotely (FICCI HealthTech Survey 2025).

  • SecondMedic Data: Users enrolled in chronic care programs show 28?wer hospitalizations and 40?tter treatment adherence.
     

 

Challenges Ahead

Despite progress, India faces key hurdles:

  • Limited digital literacy among elderly patients.

  • Unequal internet access in rural regions.

  • Need for regulatory clarity on remote prescriptions.

  • Integration between hospital and home-based care systems.
     

But with the Ayushman Bharat Digital Mission (ABDM) and telemedicine policy frameworks, these challenges are rapidly being addressed.

 

Conclusion

Chronic disease management in Digital India is not about occasional care - it’s about continuous connection.
With platforms like SecondMedic, chronic patients can now access doctors, diagnostics, and AI health tracking - all from the comfort of home.

Healthcare is no longer reactive - it’s proactive, predictive, and personal.

Take control of your health today at www.secondmedic.com

 

Real Data & References

See all

Live Doctor consultation
Live Doctor Chat

Download Our App & Get Consultation from anywhere.

App Download
call icon for mobile number calling and whatsapp at secondmedic